BG106927A - Matrix tablet for prolonged release of trimetazidine after oral administration - Google Patents

Matrix tablet for prolonged release of trimetazidine after oral administration

Info

Publication number
BG106927A
BG106927A BG106927A BG10692702A BG106927A BG 106927 A BG106927 A BG 106927A BG 106927 A BG106927 A BG 106927A BG 10692702 A BG10692702 A BG 10692702A BG 106927 A BG106927 A BG 106927A
Authority
BG
Bulgaria
Prior art keywords
prolonged release
trimetazidine
oral administration
matrix tablet
matrix
Prior art date
Application number
BG106927A
Other languages
Bulgarian (bg)
Other versions
BG65773B1 (en
Inventor
De Barochez Bruno Huet
Claude Dauphant
Patrick Wuthrich
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG106927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of BG106927A publication Critical patent/BG106927A/en
Publication of BG65773B1 publication Critical patent/BG65773B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns a matrix object for prolonged release of trimetazidine or one of its additive salts to a pharmaceutically acceptable acid after oral administration, characterised in that the prolonged release is controlled by the use of a polymer derived from cellulose. 17 claims
BG106927A 1999-12-17 2002-07-16 Orally applicable tablet matrix for sustained release of trimetazidine BG65773B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915960A FR2802424B1 (en) 1999-12-17 1999-12-17 MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
PCT/FR2000/003546 WO2001043747A1 (en) 1999-12-17 2000-12-15 Matrix tablet for prolonged release of trimetazidine after oral administration

Publications (2)

Publication Number Publication Date
BG106927A true BG106927A (en) 2003-05-30
BG65773B1 BG65773B1 (en) 2009-11-30

Family

ID=9553398

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106927A BG65773B1 (en) 1999-12-17 2002-07-16 Orally applicable tablet matrix for sustained release of trimetazidine

Country Status (32)

Country Link
EP (1) EP1108424B2 (en)
JP (2) JP2001172181A (en)
KR (1) KR100456933B1 (en)
CN (1) CN1166408C (en)
AR (1) AR026968A1 (en)
AT (1) ATE296622T1 (en)
AU (1) AU780011B2 (en)
BG (1) BG65773B1 (en)
BR (1) BR0005915A (en)
CY (1) CY2347B1 (en)
CZ (1) CZ299461B6 (en)
DE (1) DE60020501T3 (en)
DK (1) DK1108424T4 (en)
EA (2) EA008223B1 (en)
ES (2) ES2176106B1 (en)
FR (1) FR2802424B1 (en)
GE (1) GEP20053540B (en)
GR (1) GR1003658B (en)
HU (1) HU226956B1 (en)
IE (1) IE20001017A1 (en)
IT (1) IT1317075B1 (en)
LU (1) LU90700B1 (en)
MX (1) MXPA00012462A (en)
NZ (1) NZ508912A (en)
OA (1) OA12121A (en)
PL (1) PL206994B1 (en)
PT (2) PT1108424E (en)
SI (1) SI1108424T2 (en)
SK (1) SK286752B6 (en)
UA (1) UA80087C2 (en)
WO (1) WO2001043747A1 (en)
ZA (1) ZA200007548B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042972D1 (en) * 2000-10-05 2009-10-29 Usv Ltd Delayed-release drug-containing trimetazidine and method of preparation
WO2005011682A1 (en) 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. Sustained release tablet for oral use
SG126792A1 (en) * 2005-04-27 2006-11-29 Servier Lab Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
UA12297U (en) * 2005-11-24 2006-01-16 Pharma Start Ltd Liability Com Matrix tablet providing for delayed release of trimetasin
CZ300307B6 (en) * 2006-01-04 2009-04-15 Zentiva, A. S. Modified release tablet containing trimetazidine or pharmacologically acceptable salts thereof
EA009776B1 (en) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Method for preparing tablets of dihydrochloride trimethazine and composition thereof
EA009810B1 (en) * 2006-12-26 2008-04-28 Закрытое Акционерное Общество "Канонфарма Продакшн" Matrix for manufacturing tableted dosage form and method of treatment
WO2009034541A2 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
RU2362548C1 (en) * 2007-11-20 2009-07-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Matrix tablet with basis for trimetazidine dihydrochloride release, way of its reception and way of treatment
RU2377989C2 (en) * 2007-11-27 2010-01-10 Товарыство з обмэжэною видповидальнистю "Фарма Старт" Trimetazidine preparation as matrix tablet of prolonged action and method for making thereof
WO2010084397A2 (en) 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
HUE027498T2 (en) * 2009-01-30 2016-10-28 Lupin Ltd Pharmaceutical compositions of trimetazidine
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
RU2445958C2 (en) * 2010-04-20 2012-03-27 Общество с ограниченной ответственностью "Озон" (ООО "Озон") Matrix tablet with trimetazidine prolonged-release base and method for preparing it
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
EP2386302A1 (en) 2010-05-11 2011-11-16 Ranbaxy Laboratories Limited A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
EP2491930A1 (en) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
FR2978916B1 (en) * 2011-08-10 2013-07-26 Servier Lab SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS
CN102824644B (en) * 2012-09-13 2013-12-25 浙江诚意药业有限公司 High-stability sustained-release tablet prepared by using hydroxy propyl cellulose
KR20160118733A (en) 2015-04-03 2016-10-12 이인현 Hose guide apparatus for hose winder and hose winder
CN109316455B (en) * 2017-07-31 2021-05-25 北京福元医药股份有限公司 Trimetazidine hydrochloride sustained release tablet
CN109908096A (en) * 2017-12-12 2019-06-21 武汉武药科技有限公司 A kind of trimetazidine hydrochloride sustained-release tablets and preparation method thereof
WO2024218267A2 (en) * 2023-04-20 2024-10-24 Les Laboratoires Servier Novel trimetazidine solid phases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
FR2490963B1 (en) * 1980-09-30 1986-04-18 Science Union & Cie NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE
KR850006132A (en) * 1984-02-29 1985-10-02 진 크라메르, 한스 루돌프 하우스 Bromocriptine Composition
JPS61293931A (en) * 1985-06-24 1986-12-24 Teijin Ltd Slow-releasing pharmaceutical composition
JPH0625055B2 (en) * 1985-03-18 1994-04-06 日本ケミフア株式会社 Persistent tablets
EP0207638B1 (en) † 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
SE8601624D0 (en) * 1986-04-11 1986-04-11 Haessle Ab NEW PHARMACEUTICAL PREPARATIONS
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
FR2681324B1 (en) * 1991-09-18 1993-10-29 Adir Cie NOVEL TRIMETAZIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR940021051A (en) * 1993-03-03 1994-10-17 손정삼 3-step drug release sustained tablet
RU2082400C1 (en) * 1993-12-16 1997-06-27 Акционерное общество - Фармацевтическая фирма "Ник-Фарм" Method of nitroglycerol prolonged action preparing
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.

Also Published As

Publication number Publication date
HU0004966D0 (en) 2001-02-28
HU226956B1 (en) 2010-03-29
SK8632002A3 (en) 2002-10-08
AR026968A1 (en) 2003-03-05
PT102542A (en) 2001-06-29
PL206994B1 (en) 2010-10-29
AU780011B2 (en) 2005-02-24
GEP20053540B (en) 2005-06-10
BR0005915A (en) 2001-10-02
GR1003658B (en) 2001-09-05
EA200001201A3 (en) 2001-10-22
ES2240033T5 (en) 2014-01-16
DE60020501T3 (en) 2014-03-20
BG65773B1 (en) 2009-11-30
SK286752B6 (en) 2009-04-06
UA80087C2 (en) 2007-08-27
FR2802424A1 (en) 2001-06-22
MXPA00012462A (en) 2002-06-04
EA200501901A1 (en) 2006-06-30
DE60020501D1 (en) 2005-07-07
SI1108424T1 (en) 2005-10-31
WO2001043747A8 (en) 2001-09-07
WO2001043747A1 (en) 2001-06-21
ATE296622T1 (en) 2005-06-15
ES2240033T3 (en) 2005-10-16
NZ508912A (en) 2002-04-26
HUP0004966A2 (en) 2002-06-29
FR2802424B1 (en) 2002-02-15
IE20001017A1 (en) 2002-04-03
ITRM20000667A0 (en) 2000-12-14
DK1108424T3 (en) 2005-10-03
EP1108424B2 (en) 2013-09-04
LU90700B1 (en) 2007-12-03
OA12121A (en) 2003-10-20
ES2176106B1 (en) 2004-01-16
ES2176106A1 (en) 2002-11-16
JP2007314578A (en) 2007-12-06
HK1036937A1 (en) 2002-01-25
CZ20022082A3 (en) 2002-09-11
PL344564A1 (en) 2001-06-18
CZ299461B6 (en) 2008-08-06
KR20010062478A (en) 2001-07-07
KR100456933B1 (en) 2004-11-10
AU7228500A (en) 2001-06-21
SI1108424T2 (en) 2014-02-28
PT1108424E (en) 2005-08-31
ITRM20000667A1 (en) 2002-06-14
ZA200007548B (en) 2001-06-19
CY2347B1 (en) 2004-06-04
HUP0004966A3 (en) 2008-04-28
JP2001172181A (en) 2001-06-26
EA200001201A2 (en) 2001-08-27
CN1166408C (en) 2004-09-15
DK1108424T4 (en) 2013-12-16
DE60020501T2 (en) 2006-04-27
EA008223B1 (en) 2007-04-27
EP1108424A1 (en) 2001-06-20
EP1108424B1 (en) 2005-06-01
CN1302663A (en) 2001-07-11
IT1317075B1 (en) 2003-05-26

Similar Documents

Publication Publication Date Title
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
CY2460B1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors.
NO330947B1 (en) The use of oxcarbazepine-containing pharmaceutical compositions in the fasted state
BG105857A (en) Pregelatinized starch in a controlled release formulation
MY122023A (en) Colonic delivery of nicotine to treat inflammatory bowel disease
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
ZA200000169B (en) Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient.
EP0966966A3 (en) Nefazodone dosage form
PT885014E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMERS ORTO ESTER TAMPONADOS
MY125428A (en) ?-carboline drug products
NZ515339A (en) Use of macrolide compounds for the treatment of dry eye
AP2003002763A0 (en) Controlled release formulations for oral administration
AU1502995A (en) Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraiton
NO20013060L (en) Controlled release pharmaceutical preparation with tilidine mesylate as active ingredient
PL299376A1 (en) Method of making solid dosage units of controllable release
AU2697100A (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
WO2000054780A3 (en) Corticosteroid formulation
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
NZ324674A (en) Rapid release tablet comprising tolfenamic acid, alginic acid and a superdisintegrant
ATE307809T1 (en) NOVEL PYRIMIDINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
AP2001002349A0 (en) Polymorphs of a crystalline azabicyclo (2,2,2) octain-3-amine citrate and their pharmaceutical compositions.
BG104692A (en) Extended release tiagabine formulation
BG106428A (en) Pharmaceutical compositions for treating psoriasis
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors